Shockwave Medical has filed a patent for an apparatus that uses shock waves to treat calcified lesions in blood vessels or calcified aortic valves. The device includes a balloon that can be placed near the affected area and inflated with liquid. Inside the balloon, there is a shock wave generator with multiple shock wave sources. When a high voltage pulse is applied, arcs are generated in the fluid, creating shock waves that target the calcified region. GlobalData’s report on Shockwave Medical gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Shockwave Medical Inc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Shockwave Medical, smart surgical instruments was a key innovation area identified from patents. Shockwave Medical's grant share as of September 2023 was 47%. Grant share is based on the ratio of number of grants to total number of patents.

Device for generating shock waves for treating calcified lesions

Source: United States Patent and Trademark Office (USPTO). Credit: Shockwave Medical Inc

A recently filed patent (Publication Number: US20230310073A1) describes a device designed to generate shock waves for the treatment of calcified lesions within blood vessels or calcified aortic valves. The device consists of an elongated support with a fluid-fillable chamber mounted on it. The chamber contains multiple pairs of electrodes, with each pair consisting of a first wire and a second wire. The distal end of the first wire serves as the first electrode, while the distal end of the second wire serves as the second electrode in the most distal pair.

One notable feature of the device is that the surface area of one electrode in each pair is greater than the surface area of the other electrode. This arrangement allows for the generation of arcs in the fluid adjacent to each electrode pair when a high voltage pulse is applied to the proximal ends of the first and second wires. These arcs create a series connection between the wires and the intermediate electrode pairs, resulting in the generation of shock waves from each electrode pair.

The device's ability to generate shock waves is particularly useful for the treatment of calcified lesions within blood vessels or calcified aortic valves. Shock wave therapy has been shown to be effective in breaking down calcifications and improving blood flow in these areas. By utilizing multiple electrode pairs with varying surface areas, the device can generate shock waves from different locations, allowing for targeted treatment of the calcified lesions.

Overall, this patent describes a novel device for generating shock waves for the treatment of calcified lesions within blood vessels or calcified aortic valves. The device's unique electrode arrangement and ability to generate shock waves from multiple locations make it a promising tool for improving the treatment of these conditions.

To know more about GlobalData’s detailed insights on Shockwave Medical, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies